Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.
Category: General
A message from CEO David Loew
Hear what CEO David Loew has to say about our H1 2022 results.
How to transform the medical organization in specialty care to drive best-in-class patient value
By Steven Hildemann, MD, PhD, EVP, Chiel Medical Officer Medical affairs play a central role at Ipsen, where our strategy
Ukraine situation: What Ipsen is doing
Latest Update: March 29, 2022 The on-going tragedy in Ukraine is profoundly worrying, and our thoughts are with everyone impacted.
Our pledge: summaries in plain language for all journal publications
Today, we are broadening our commitment to providing everyone with the opportunity to read and understand our research. From July
Ipsen continues to strengthen early oncology pipeline with Queen’s University Belfast collaboration and licensing agreement.
Today we are pleased to announce a partnership with the Queen’s University of Belfast (QUB), securing rights to a preclinical
Reuters Events Pharma 2021: Transforming Medical Affairs to drive patient value
By Steven Hildemann, MD, PhD, EVP, Chiel Medical Officer Today at Reuters Events Pharma 2021, I was honoured to speak
Ipsen’s Signes production site has received the Shingo (Gold) Award
Ipsen’s Signes production site has received the Shingo (Gold) Award, the highest and most demanding distinction in operational excellence in
Ipsen announces the arrival of Gwenan White, EVP Communications & Public Affairs
We are pleased to announce the arrival of Gwenan White as Executive Vice President, Communications and Public Affairs, effective 1
Ipsen and the fight against corruption
Today is International Anti-Corruption Day. We are all aware that corruption has the potential to impact the social and economic